0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Another Side Effect of NSAIDs

George R. Gay, MD
JAMA. 1990;264(20):2677-2678. doi:10.1001/jama.1990.03450200085037.
Text Size: A A A
Published online

The nonsteroidal anti-inflammatory drugs (NSAIDs) have enjoyed a generally laudatory press, their acronym implying neither steroid nor narcotic mechanism of action. They encompass a heterogeneous group of compounds, mostly organic acids, that appear to owe their therapeutic efficacy to an inhibition of the biosynthesis of prostaglandins. They exhibit very real analgesic and antipyretic actions as well as being anti-inflammatory (acetaminophen and phenacetin are not NSAIDs, lacking anti-inflammatory action), are surely our major pharmacologic tools in the treatment of rheumatic and arthritic disorders, and as such enjoy an expanding global utilization and popularity. The NSAIDs do, however, share certain therapeutic side effects as well as benefits.1 Aspirin, the prototype NSAID (available since 1898), indomethacin (for over 35 years), phenylbutazone, and other older NSAIDs have a long track record of clinical efficacy and "relative" safety.

Hepatotoxicity, however, is an increasingly recognized laboratory abnormality and a rare clinical side effect of the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();